PRECISION BIOSCIENCES INC

DTIL · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
165
SEC Filings

Business Summary

PART I . We are a clinical stage gene editing company utilizing our novel proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. ARCUS differs from other technologies in the way it cuts, its smaller size, and its simpler structure. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. ...

Next Earnings

Q2 FY2026 — expected 2026-09-06

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionDTILdiscussed_in_filing Cybersecurity
topic_mentionDTILdiscussed_in_filing Trusted Computing
topic_mentionDTILdiscussed_in_filing Blockchain & Crypto
topic_mentionDTILdiscussed_in_filing Supply Chain
topic_mentionDTILdiscussed_in_filing Regulation
topic_mentionDTILdiscussed_in_filing Automotive
topic_mentionDTILdiscussed_in_filing Healthcare & Bio
topic_mentionDTILdiscussed_in_filing Platform & Ecosystem
topic_mentionDTILdiscussed_in_filing Cybersecurity
topic_mentionDTILdiscussed_in_filing Trusted Computing
topic_mentionDTILdiscussed_in_filing Blockchain & Crypto
topic_mentionDTILdiscussed_in_filing Supply Chain
topic_mentionDTILdiscussed_in_filing Regulation
topic_mentionDTILdiscussed_in_filing Automotive
topic_mentionDTILdiscussed_in_filing Healthcare & Bio
topic_mentionDTILdiscussed_in_filing Platform & Ecosystem
topic_mentionDTILdiscussed_in_filing Cybersecurity
topic_mentionDTILdiscussed_in_filing Trusted Computing
topic_mentionDTILdiscussed_in_filing Blockchain & Crypto
topic_mentionDTILdiscussed_in_filing Supply Chain

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001628280-26-017019EDGAR105K words
2025-03-262024-12-310000950170-25-044775EDGAR
2024-03-272023-12-310000950170-24-036817EDGAR
2023-03-092022-12-310000950170-23-006838EDGAR
2022-03-152021-12-310001564590-22-010222EDGAR
2021-03-182020-12-310001564590-21-014005EDGAR
2020-03-102019-12-310001564590-20-009541EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-032025-09-300001628280-25-047919EDGAR63K words
2025-08-072025-06-300001628280-25-038594EDGAR
2025-05-152025-03-310000950170-25-071991EDGAR
2024-11-042024-09-300000950170-24-120279EDGAR
2024-08-012024-06-300000950170-24-088951EDGAR
2024-05-132024-03-310000950170-24-058192EDGAR
2023-11-072023-09-300000950170-23-059764EDGAR
2023-08-042023-06-300000950170-23-038319EDGAR
2023-05-092023-03-310000950170-23-019132EDGAR
2022-11-082022-09-300000950170-22-022893EDGAR
2022-08-082022-06-300001564590-22-028299EDGAR
2022-05-092022-03-310001564590-22-018698EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-170001628280-26-018397EDGAR5K words
2026-03-120001628280-26-017018EDGAR
2026-02-110001628280-26-007114EDGAR
2026-01-130001628280-26-001955EDGAR
2025-11-120001628280-25-051382EDGAR
2025-11-100001628280-25-051168EDGAR
2025-11-030001628280-25-047920EDGAR
2025-09-020001357874-25-000005EDGAR
2025-08-070001628280-25-038592EDGAR
2025-08-060001628280-25-038094EDGAR

165 total filings indexed. 136 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001357874
TickerDTIL
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 899c4475ce1b1992bb6c54747bd87efeb188262937db1c4a54d558adce478dad
parent: bfaf4c2893aa465c04752a3df9caa34aec1c9a22ab14da942b68673ddcdb6908
content hash: 562a45dec6aae6db68f38f4860439a8eef8035269549eee563d0fb5ea431d225
signed: 2026-04-13T04:44:44.208Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf